• Subscribe

    Webinars & Whitepapers →

    ▾
  • Xconomy National

  • Xperience
    Tech + Life
      • Fetch Rewards Grabs $25M, Plans to Double Staff as Growth Accelerates
        Fetch Rewards Grabs $25M, Plans to Double Staff as Growth Accelerates
      • Nuance Spinout Cerence Vies With Tech Giants in Voice-AI for Auto
        Nuance Spinout Cerence Vies With Tech Giants in Voice-AI for Auto
      • Can Ford’s Self-Driving Car Business Improve Austin’s Traffic Woes?
        Can Ford’s Self-Driving Car Business Improve Austin’s Traffic Woes?
      • John Halamka, Livongo Health & AI Progress at X·CON on Oct. 22
        John Halamka, Livongo Health & AI Progress at X·CON on Oct. 22
      • As More Grocers Embrace Tech, Swiftly Snags $15M to Launch in Seattle
        As More Grocers Embrace Tech, Swiftly Snags $15M to Launch in Seattle
      View More in Xperience ›
  • EXOME
    Biotech + Health
      • Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink
        Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink
      • Flagship’s Cellarity Aims to Advance Cell Behavior-Based Therapeutics
        Flagship’s Cellarity Aims to Advance Cell Behavior-Based Therapeutics
      • KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test
        KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test
      • Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules
        Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules
      • Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer
        Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer
      View More in EXOME ›
  • Our
    Regions
    • Boston ›
      • Flagship’s Cellarity Aims to Advance Cell Behavior-Based Therapeutics
        Flagship’s Cellarity Aims to Advance Cell Behavior-Based Therapeutics
      View More in Boston ›
    • Boulder/Denver ›
      • PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
        PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
        Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test
        Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test
      View More in Indiana ›
    • New York ›
      • Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules
        Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules
      View More in New York ›
    • Raleigh-Durham ›
      • Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%
        Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%
      View More in Raleigh-Durham ›
    • San Diego ›
      • Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules
        Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules
      View More in San Diego ›
    • San Francisco ›
      • BridgeBio Pharma Onboards Eli Wallace to Lead Oncology Programs
        BridgeBio Pharma Onboards Eli Wallace to Lead Oncology Programs
      View More in San Francisco ›
    • Seattle ›
      • A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns
        A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns
      View More in Seattle ›
    • Texas ›
      • Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing
        Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing
      View More in Texas ›
    • Wisconsin ›
      • AI Can Unlock Health Data's Potential, But Access Is Still Difficult
        AI Can Unlock Health Data's Potential, But Access Is Still Difficult
      View More in Wisconsin ›
  • Tech
    Channels
    • Agtech and Food›
      • Gojee Finds Its Way Into the Food Spotlight, Enters Talks for First Round of Funding
      View More in Agtech and Food ›
    • Cleantech›
        View More in Cleantech ›
      • Cybersecurity›
          View More in Cybersecurity ›
        • Education›
            View More in Education ›
          • EXOME: Biotech + Health›
            • Avidity Bio Adds $100M to Advance R&D of Muscle Disorder Drugs
              Avidity Bio Adds $100M to Advance R&D of Muscle Disorder Drugs
            View More in EXOME ›
          • Fintech›
              View More in Fintech ›
            • Healthtech›
              • AI Can Unlock Health Data’s Potential, But Access Is Still Difficult
                AI Can Unlock Health Data’s Potential, But Access Is Still Difficult
              View More in Healthtech ›
            • Robotics and A.I.›
              • AI Can Unlock Health Data’s Potential, But Access Is Still Difficult
                AI Can Unlock Health Data’s Potential, But Access Is Still Difficult
              View More in Robotics and A.I. ›
            • Startups›
              • Five Questions With a16z’s Vijay Pande on AI and Making New Drugs
                Five Questions With a16z’s Vijay Pande on AI and Making New Drugs
              View More in Startups ›
            • Xperience: Tech + Life›
                View More in Xperience ›
            • Meet the
              Xconomists
              • Bryony Winn

                Bryony Winn

                Chief Strategy and Innovation Officer, Blue Cross and Blue Shield of North Carolina

              • Alfred Spector

                Alfred Spector

                VP of Research and Special Initiatives, Google

              • David Johnson

                David Johnson

                President and CEO of the Central Indiana Corporate Partnership

              • Ann Marie Sastry

                Ann Marie Sastry

                Co-Founder, Sakti3

              • Meet All the Xconomists ›
              • Dane Stangler

                Dane Stangler

                VP of Research & Policy, Ewing Marion Kauffman Foundation

              • Brad Feld

                Brad Feld

                Managing director, the Foundry Group

              • Gerry Hays

                Gerry Hays

                Serial Entrepreneur and Investor

              • Alan Saltiel

                Alan Saltiel

                Director, Life Sciences Institute, University of Michigan

            • Our
              Events
              • All Xconomy Events › Boston Events ›
              • Boulder/Denver Events › Detroit/Ann Arbor Events ›
              • Indiana Events › New York Events ›
              • Raleigh-Durham Events ›San Diego Events ›
              • San Francisco Events ›Seattle Events ›
              • Texas Events › Wisconsin Events ›
            • Xpertise
              Watch + Learn

            “actemra” Archives

            in
            Entry Author Date Location
            West Coast Biotech Roundup: PCSK9, Amgen, SeaGen, Twist, Serenus Alex Lash 06/11/15 Seattle
            Eleven Biotherapeutics Raises $35M, Seeks to Crank the Amplifer Up on Protein Drugs Luke Timmerman 02/17/10 Boston
            Alder Scores Deal With Bristol-Myers Potentially Worth $1 Billion Luke Timmerman 11/10/09 Seattle
            Invest Northwest Notebook: Five of Seattle’s Next-Generation Life Sciences Innovators Seek to Adapt Luke Timmerman 03/19/09 Seattle
            Alder Gets Early Christmas Present: FDA Slaps Down Its Rival, Roche Luke Timmerman 12/08/08 Seattle
            Alder Sets Stage for Showdown With Roche, With “Fast Follower” Antibody Drug Strategy Luke Timmerman 09/18/08 Seattle
            Page 1 of 1

            Underwriters and Partners

            Xpertise: Watch + Learn
            • Digitizing 10 Life Sciences Paper Processes

              Sponsored · Whitepaper

              Digitizing 10 Life Sciences Paper Processes

              How to accelerate your life sciences business with every agreement

              DocuSign
            • What to Include in Your Life Sciences Company Fundraising Pitch Deck

              Sponsored · Whitepaper

              What to Include in Your Life Sciences Company Fundraising Pitch Deck

              What the most successful life sciences fundraising pitch decks all have in common

              Brex
            • Accelerating Life Sciences Product Development & Commercialization

              Sponsored · Whitepaper

              Accelerating Life Sciences Product Development & Commercialization

              Best practices to drive digital adoption in life sciences

              DocuSign

            Connect with Xconomy

            • Xconomy on Facebook
            • Xconomy on Twitter
            • Xconomy on Linkedin
            • Xconomy on Google PLus
            • Xconomy Feeds

            Xconomy on Demand

            Did you miss something? Don't despair…

            Xconomy offers a number of ways to subscribe for free!

            Subscribe Now
            IDG Tech Network
            Protected by Carbonite
            Eventbrite - events made easy
            • Home
            • Privacy/DMCA
            • Security Disclosures
            • About
            • Contact Us
            • Archives
            • Advertise
            • Subscribe for Free

            Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

            © 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

            Website development support from Andrew Koyfman with design support from Rob Hunter.